Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mereo BioPharma (MREO) Non Operating Income (2023)

Historic Non Operating Income for Mereo BioPharma (MREO) over the last 1 years, with Q4 2023 value amounting to -$4000.0.

  • Mereo BioPharma's Non Operating Income changed N/A to -$4000.0 in Q4 2023 from the same period last year, while for Sep 2024 it was -$4000.0, marking a year-over-year change of. This contributed to the annual value of -$10000.0 for FY2023, which is 10092.08% down from last year.
  • Latest data reveals that Mereo BioPharma reported Non Operating Income of -$4000.0 as of Q4 2023.
  • In the past 5 years, Mereo BioPharma's Non Operating Income ranged from a high of -$4000.0 in Q4 2023 and a low of -$6000.0 during Q1 2023